Approval · Notice of Compliance 1871 · 1999
INFERGEN: Notice of Compliance 1871
Issued March 9, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1871
- Date
- March 9, 1999
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFERGEN | 02239832 | Cancelled Post Market |
Medicinal ingredients
- INTERFERON ALFACON-1 0.03 MG per ML